MedTrace Logo

Incidence of Residual Neuromuscular Blockade in Fraility in OncoGynae Surgery

NCT06216002 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 622

Last updated 2025-05-08

No results posted yet for this study

Summary

Frailty among patients undergoing surgery is strongly associated with an elevated risk of adverse perioperative outcomes, heightened incidence of postoperative complications, increased mortality rates, and prolonged hospital length of stay. Our focus centers on investigating the frailty index in the context of complications experienced by patients undergoing oncologic gynecology surgery. The principal objective of this research is to elucidate the extent to which residual neuromuscular blocking agents are linked to frailty.

Conditions

  • Frailty
  • Neuromuscular Blockade
  • General Anesthetic Drug Adverse Reaction
  • Gynecologic Cancer
  • Surgical Complication

Interventions

DIAGNOSTIC_TEST

Train of four nerve stimulator

Patient receive nerve stimulation by TOF-scan equipment at recovery room after surgery.

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Patchareya Nivatpumin, M.D. · Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University

  • Jitsupa Nithiuthai, M.D. · Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-02
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06216002 on ClinicalTrials.gov